Combination of Anlotinib and Temozolomide Results in Sustained Response in Multimodal-Resistant Primary Breast Angiosarcoma with Metastasis to Skull Base and Dural Involvement: A Case Study - Quiz - MDSpire

Combination of Anlotinib and Temozolomide Results in Sustained Response in Multimodal-Resistant Primary Breast Angiosarcoma with Metastasis to Skull Base and Dural Involvement: A Case Study

  • By

  • Shujie Song

  • Weiyi Chen

  • Xixi Li

  • Yongxia Zhang

  • Yanchun Wang

  • April 27, 2026

  • 0 min

Share

Original Source(s)

Combination of Anlotinib and Temozolomide Results in Sustained Response in Multimodal-Resistant Primary Breast Angiosarcoma with Metastasis to Skull Base and Dural Involvement: A Case Study

  • by Shujie Song, Weiyi Chen, Xixi Li, Yongxia Zhang, Yanchun Wang

  • April 27, 2026

Related Content

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

VANGL1 links angiogenesis–stemness programs and tumor microenvironment remodeling: a pan-cancer, multi-omics study with translational validation

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases